VMD earnings / call / takeaways

VMD Q3 FY26 earnings call: key takeaways

What VMD said on its earnings call of November 5, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.

By Lician·November 5, 2026·AI-generated from the call transcript and Lician data

ViMed reported revenue of $80.7 million, matching the $80.78 million consensus estimate (12:32)
EPS was $0.11, below the $0.12 consensus (17:25)
The company raised full-year revenue guidance to $316 million to $320 million. (24:10)

Results vs expectations

Metric	Consensus	Reported	Result
EPS	$0.12	–	–
Revenue	$80.8M	–	–

EPS basis: Provider EPS (EODHD), not yet checked against the SEC

What changed since last quarter

The company raised full-year revenue guidance to $316 million to $320 million, up from $314 million to $320 million (24:10)
Adjusted EBITDA guidance was narrowed to $64 to $66 million, down from $64 to $68 million (24:10)
The company also lowered net capex guidance to 8% to 9% of revenue, down from 8.5% to 10%. (24:10)

Guidance

Metric	This call	Previous call
Revenue	Full-year revenue guidance raised to $316 million to $320 million. (24:10)	not captured
EBITDA	Adjusted EBITDA guidance narrowed to $64 million to $66 million. (24:10)	not captured
Revenue	Net capex outlook lowered to 8% to 9% of revenue. (24:10)	not captured

What analysts pressed on

"- Whether the decline in event patient numbers is due to NCD compliance hurdles " (30:21)
"- Concerns about the impact of audit activity on cash flow " (41:33)

In their words

We are now on track to enter two additional states per quarter, beginning in the fourth quarter Casey Hoyt (12:32)
We see an opportunity for more targeted, consistent oversight Casey Hoyt (17:25)
We're super excited about it. We expect to continue to grow it (35:30)
It's an area that we have a lot of success in. That's our organic model (41:10)

Read the full transcript with the AI summary, or listen on the company's official webcast.

Every past call in full and transcript search come with Lician Pro.

Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.